Mitsu Chem Plast Ltd
P&L
Quarterly Standalone
vs Q3 FY25
Mitsu Chem Plast Limited Reports 25% YoY Growth in PAT for Q4 FY25, Sets ₹ 31,000 Cr Milestone by 2028
09 May 2025 · 9 May 2025, 02:30 am
Summary
Mitsu Chem Plast Limited, a leading global manufacturer of Blow moulded & Injection Moulded products and a specialist in hospital furniture components, Infrastructure Products, Packaging Bottles Drums, Jerrycan, Pails and Caps, has announced its Audited Financial Results for Q4 FY25 & FY25. The company reported a 25% YoY growth in PAT for Q4 FY25, reaching ₹ 3.54 Cr. The total income for FY25 stood at ₹ 332.88 Cr, with an EBITDA of ₹ 23.28 Cr and a PAT of ₹ 37.25 Cr. The company also introduced Furnastra, a dedicated brand for healthcare furniture solutions and demonstrated strong growth in its export operations, recording a 144% YoY increase in export value in FY25.
Key Highlights
- 1
Mitsu Chem Plast Limited reported a 25% YoY growth in PAT for Q4 FY25, reaching ₹ 3.54 Cr.
- 2
The total income for FY25 stood at ₹ 332.88 Cr, with an EBITDA of ₹ 23.28 Cr and a PAT of ₹ 37.25 Cr.
- 3
The company introduced Furnastra, a dedicated brand for healthcare furniture solutions.
- 4
Mitsu Chem Plast demonstrated strong growth in its export operations, recording a 144% YoY increase in export value in FY25.
- 5
The company has set a goal to reach the ₹ 31,000 Cr milestone by 2028.
Management Comments
Mr. Jagdish Dedhia
Chairman of Mitsu Chem Plast Limited
In FY25, we delivered a total income of ₹ 332.88 Cr, an EBITDA of ₹ 23.28 Cr, a PAT of ₹ 37.25 Cr and an EPS of ₹ 5.39, figures that underscore the resilience and balanced execution of our business model. We're also proud of the strong export momentum we've built, proof of our product quality and the trust of partners around the world which has paved the way for Furnastra, our dedicated healthcare-furniture brand designed to meet rising demand for durable, ergonomic solutions in hospitals and care facilities. Sustainability underpins everything we do, from sourcing eco-friendly materials to driving energy and waste efficiencies in our operations. Looking ahead, we’ve set our sights on reaching the ₹ 31,000 Cr milestone by 2028 a goal that extends our 35-year legacy of innovation and customer focus. It’s not just about scaling revenues; it’s about improving patient care worldwide through Furnastra’s advanced polymer solutions. With our export strength, targeted brand expansion, and unwavering commitment to sustainable practices, we’re well- positioned to capture new opportunities and deliver lasting value for all stakeholders.
Informational and educational content only. Not investment advice.